Duke Clinical Research Institute

Duke Clinical Research Institute
Name	Duke Clinical Research Institute
Established	1969
Parent	Duke University
Director	Adrian Hernandez
Location	Durham, North Carolina
Website	dcri.org

Duke Clinical Research Institute is a premier academic clinical research organization embedded within the Duke University School of Medicine. Founded in 1969, it has grown into one of the world's largest academic research enterprises, dedicated to developing and sharing knowledge that improves the care of patients worldwide through innovative clinical research. The institute operates across the entire spectrum of medical investigation, from designing and managing large-scale multinational clinical trials to conducting pragmatic studies and analyzing real-world data.

History and founding

The origins trace back to 1969 when Dr. Robert W. Anderson established the Duke Databank for Cardiovascular Diseases, a pioneering registry that systematically collected data on patients undergoing cardiac catheterization at Duke University Medical Center. This foundational work, championed by renowned cardiologist Dr. Eugene Braunwald, created a model for leveraging clinical data to answer critical research questions. Under the leadership of subsequent directors like Dr. Robert M. Califf and Dr. Eric D. Peterson, the institute expanded its scope far beyond cardiology. Its evolution was marked by a strategic emphasis on developing methodologies for clinical trial design and fostering close integration with the U.S. Food and Drug Administration and the National Institutes of Health.

Research focus and areas

Its research portfolio is exceptionally broad, though it maintains deep roots and global leadership in cardiovascular disease research, including studies on acute coronary syndrome, heart failure, and atrial fibrillation. Major areas of focus extend to neurocritical care, pediatric therapeutics, diabetes mellitus, infectious diseases, and oncology. The institute is also a leader in the field of pragmatic clinical trials, which test treatments in real-world healthcare settings, and in the science of patient-reported outcomes. It houses specialized centers like the Duke Translational Medicine Institute and applies advanced methodologies in biostatistics, health economics, and data science to transform healthcare delivery and policy.

Major clinical trials and studies

The institute has coordinated or played a central role in numerous landmark studies that have reshaped medical practice. In cardiology, pivotal trials include the SYNTAX trial, which compared treatments for complex coronary artery disease, and the PLATO trial, which evaluated antiplatelet therapies. It has managed major National Heart, Lung, and Blood Institute initiatives like the Cardiovascular Cell Therapy Research Network. Beyond cardiovascular medicine, its impact is seen in influential studies such as the ADAPTABLE trial, a pioneering pragmatic study on aspirin dosing, and the I-SPY 2 trial for breast cancer. Its work on the PREVENT study informed guidelines for hospital-acquired infection prevention.

Organizational structure and leadership

The institute is an integral part of Duke University Health System and operates under the auspices of the Duke University School of Medicine. It is led by an executive director, a position held by Dr. Adrian Hernandez, who also serves as Vice Dean of the School of Medicine. The organization comprises numerous thematic research groups and support units, including divisions dedicated to clinical trials operations, biostatistics and bioinformatics, and health services research. Its governance involves close collaboration with senior leadership from Duke University Medical Center and relies on a large, multidisciplinary faculty and staff of clinicians, statisticians, project managers, and data scientists.

Impact and recognition

The institute's impact is measured by its profound influence on clinical guidelines issued by bodies like the American College of Cardiology and the American Heart Association. Its research has directly informed regulatory decisions by the U.S. Food and Drug Administration and shaped national healthcare policy. The faculty are frequently recognized with prestigious awards, including the American Heart Association's Distinguished Scientist designation. Its educational programs train the next generation of clinical researchers, and its methodological contributions to trial design and data analysis are widely adopted across the global academic research community.

Collaborations and partnerships

It maintains an extensive network of collaborations with a diverse array of partners. This includes long-standing research partnerships with federal agencies like the National Institutes of Health, the Centers for Medicare & Medicaid Services, and the U.S. Department of Veterans Affairs. The institute frequently collaborates with other leading academic centers worldwide, such as the Cleveland Clinic and Stanford University School of Medicine. It also works closely with the biopharmaceutical and device industry on collaborative research and with non-profit foundations like the American Heart Association and the Bill & Melinda Gates Foundation to address global health challenges.

Category:Medical and health organizations based in North Carolina Category:Duke University Category:Medical research institutes in the United States